Sygnis said today it plans to acquire Expedeon Holdings, a developer, manufacturer, and commercializer of proteomics reagents and tools.
Expedeon’s protein research offerings include RunBlue® gels for electrophoresis, the VersaWave spectrophotometer for quantitation, and NVoy kits for refolding proteins. Expedeon manufactures and sells its products through a direct sales force as well as through established distribution channels.
Expedeon’s protein research offerings include RunBlue® gels for electrophoresis, the VersaWave spectrophotometer for quantitation, and NVoy kits for refolding proteins. Expedeon manufactures and sells its products through a direct sales force as well as through established distribution channels.
